Key facts
Alloy Therapeutics, Inc.
New Form D on file · 2021-04-02 · the record
What the record says
Each marker is one filing. The larger marker is the filing this page is about.
Company officers on record
Jason Coloma is named as Director on the Form D that Alloy Therapeutics, Inc. filed with the SEC on 2 April 2021, one of 9 people that filing names.
Errik Anderson is named as Executive Officer and Director on the Form D that Alloy Therapeutics, Inc. filed with the SEC on 2 April 2021, one of 9 people that filing names.
Logan Snyder is named as Executive Officer and Director on the Form D that Alloy Therapeutics, Inc. filed with the SEC on 2 April 2021, one of 9 people that filing names.
Ulrik Nielsen is named as Director on the Form D that Alloy Therapeutics, Inc. filed with the SEC on 2 April 2021, one of 9 people that filing names.
Jason Camm is named as Director on the Form D that Alloy Therapeutics, Inc. filed with the SEC on 2 April 2021, one of 9 people that filing names.
Alex Kolicich is named as Director on the Form D that Alloy Therapeutics, Inc. filed with the SEC on 2 April 2021, one of 9 people that filing names.
Piotr Bobrowicz is named as Executive Officer and Director on the Form D that Alloy Therapeutics, Inc. filed with the SEC on 2 April 2021, one of 9 people that filing names.
On the filing as: Director.
Fabian Hansen is named as Mr. Hansen was elected as a Director subsequent to the Date of First Sale. on the Form D that Alloy Therapeutics, Inc. filed with the SEC on 2 April 2021, one of 9 people that filing names.
Jay Rosanelli is named as Executive Officer on the Form D that Alloy Therapeutics, Inc. filed with the SEC on 2 April 2021, one of 9 people that filing names.
9 people named on the filing — 4 holding an executive role and 5 as directors only.
Named as of the 2021-04-02 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
- 9 people named on the filing — 4 holding an executive role and 5 as directors only.
No investor is drawn from a Form D — the form states how many invested and never who.
Want the whole picture on Alloy Therapeutics, Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Alloy Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Alloy Therapeutics, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
1 cited source found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
The full profile
Source Check, INVEST, RECRUIT and Press Requests on Alloy Therapeutics, Inc.
- Source Check — verify Errik B. Anderson's other claims against the registers that hold them.
- INVEST — size up this raise on the figures the filing states.
- RECRUIT — see who is already on the team.
- Press Requests — connect with Errik B. Anderson for a story.
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Alloy Therapeutics, Inc.You get an alert in MentionFox the next time this company shows up.
Is this you?
If you're behind Alloy Therapeutics, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. FoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.